Healthcare provider profile · identity verified

Jose E Benamu, MD

Internal Medicine · CORPUS CHRISTI, TX · NPI 1760481873

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1264	380
Amlodipine Besylate	Amlodipine Besylate	765	225
Losartan Potassium	Losartan Potassium	701	214
Metformin Hcl	Metformin Hcl	675	209
Lisinopril	Lisinopril	670	207
Levothyroxine Sodium	Levothyroxine Sodium	636	184
Omeprazole	Omeprazole	445	135
Simvastatin	Simvastatin	376	118
Pantoprazole Sodium	Pantoprazole Sodium	310	104
Gabapentin	Gabapentin	278	104
Tamsulosin Hcl	Tamsulosin Hcl	259	87
Pioglitazone Hcl	Pioglitazone Hcl	240	70
Hydralazine Hcl	Hydralazine Hcl	238	69
Albuterol Sulfate Hfa	Albuterol Sulfate	228	70
Metoprolol Succinate	Metoprolol Succinate	218	71
Metoprolol Tartrate	Metoprolol Tartrate	217	72
Clopidogrel	Clopidogrel Bisulfate	216	71
Fluticasone Propionate	Fluticasone Propionate	214	92
Mounjaro	Tirzepatide	203	36
Trulicity	Dulaglutide	176	32
Sertraline Hcl	Sertraline Hcl	172	58
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	171	52
Hydrochlorothiazide	Hydrochlorothiazide	168	58
Glimepiride	Glimepiride	163	44
Furosemide	Furosemide	160	64
Alendronate Sodium	Alendronate Sodium	155	44
Famotidine	Famotidine	151	55
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	148	62
Rosuvastatin Calcium	Rosuvastatin Calcium	145	45
Pravastatin Sodium	Pravastatin Sodium	140	41
Tizanidine Hcl	Tizanidine Hcl	130	73
Jardiance	Empagliflozin	123	35
Allopurinol	Allopurinol	122	37
Eliquis	Apixaban	116	39
Montelukast Sodium	Montelukast Sodium	116	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	104	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	102	24
Carvedilol	Carvedilol	93	29
Metformin Hcl Er	Metformin Hcl	93	29
Trazodone Hcl	Trazodone Hcl	91	32
Potassium Chloride	Potassium Chloride	84	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	77	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	76	67
Symbicort	Budesonide/Formoterol Fumarate	73	26
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	67	28
Ozempic	Semaglutide	65	13
Enalapril Maleate	Enalapril Maleate	64	20
Finasteride	Finasteride	63	19
Meloxicam	Meloxicam	63	28
Sucralfate	Sucralfate	63	17
Duloxetine Hcl	Duloxetine Hcl	61	15
Ezetimibe	Ezetimibe	60	20
Azithromycin	Azithromycin	59	56
Buspirone Hcl	Buspirone Hcl	56	19
Atenolol	Atenolol	55	14
Diclofenac Sodium	Diclofenac Sodium	55	27
Escitalopram Oxalate	Escitalopram Oxalate	53	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	51	46
Oxybutynin Chloride Er	Oxybutynin Chloride	51	16
Vitamin D2	Ergocalciferol (Vitamin D2)	48	14
Benazepril Hcl	Benazepril Hcl	47	15
Doxazosin Mesylate	Doxazosin Mesylate	44	11
Methylprednisolone	Methylprednisolone	44	43
Quetiapine Fumarate	Quetiapine Fumarate	44	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	15
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Spironolactone	Spironolactone	41	13
Prednisone	Prednisone	40	22
Triamcinolone Acetonide	Triamcinolone Acetonide	40	21
Doxycycline Hyclate	Doxycycline Hyclate	37	33
Lactulose	Lactulose	36	18
Dicyclomine Hcl	Dicyclomine Hcl	35	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	29
Folic Acid	Folic Acid	34	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	34	34
Solifenacin Succinate	Solifenacin Succinate	34	suppressed
Gemfibrozil	Gemfibrozil	33	11
Mirtazapine	Mirtazapine	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	32	14
Glipizide	Glipizide	31	12
Nifedipine Er	Nifedipine	31	suppressed
Nitroglycerin	Nitroglycerin	31	15
Ondansetron Hcl	Ondansetron Hcl	31	22
Warfarin Sodium	Warfarin Sodium	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	11
Ibuprofen	Ibuprofen	30	22
Lovastatin	Lovastatin	30	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	14
Mupirocin	Mupirocin	29	22
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Clotrimazole	Clotrimazole	25	13
Donepezil Hcl	Donepezil Hcl	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	15
Telmisartan	Telmisartan	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Sildenafil Citrate	Sildenafil Citrate	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Incontrol Pen Needle	Pen Needle, Diabetic	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Valsartan	Valsartan	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Calcium Acetate	Calcium Acetate	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Constulose	Lactulose	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error